The aim of this study was to confirm the efficacy of a commercial vaccine containing Histophilus somni and Mannheimia haemolytica leukotoxoid (HIPRABOVIS® SOMNI/Lkt) in reducing clinical respiratory signs and the number of concomitant treatments under field conditions.
Efficacy of a commercial vaccine containing Histophilus somni and Mannheimia haemolytica leukotoxoid (HIPRABOVIS® SOMNI/Lkt) under field conditions
Ấn phẩm
Gia súc
Tải về bài báo này
Những ấn phẩm liên quan
Tin tức mới nhất
Khám phá những tin tức mới nhất của chúng tôi